# US 2025/0151774 A1 · Nicotine salt formulations for aerosol devices and methods thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0151774 A1
- Document ID: US20250151774A1
- Status: Published application
- Kind: A1
- Application number: 19/024,843
- Filed: 2025-01-16
- Published: 2025-05-15
- Earliest claimed: 2013-05-06
- Assignees: JUUL Labs, Inc.
- Applicants: JUUL Labs, Inc.
- Inventors: Adam Bowen; Chenyue Xing
- Web page: https://patentgrep.com/patent/US20250151774A1

## CPC

- A24B 15/167: in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
- A24B 15/16: of tobacco substitutes
- A61K 9/007: {Pulmonary tract; Aromatherapy}
- A61K 9/12: Aerosols; Foams {(A61K9/0043, A61K9/0056, A61K9/006, A61K9/0073 take precedence; spray-films A61K9/7015)}
- A61K 31/465: Nicotine; Derivatives thereof
- A61K 31/60: Salicylic acid; Derivatives thereof
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61P 25/26: Psychostimulants, e.g. nicotine, cocaine
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A24F 40/10: Devices using liquid inhalable precursors
- A24B: MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A24F: SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES (inhaling appliances for medical purposes, shaped like cigars, cigarettes or pipes A61M15/06)

## Abstract

A nicotine salt liquid formulation for generating an inhalable aerosol in an electronic cigarette comprising nicotine salt that forms about 0.5% to about 20% nicotine is provided.

## Claims

### Claim 1

An electronic cigarette cartridge comprising a nicotine salt liquid formulation, wherein:
(a) the nicotine salt liquid formulation comprises a salt of nicotine and an organic acid in a liquid carrier;
(b) the salt is present in an amount that forms a nicotine concentration of 0.5% (w/w) to 20% (w/w) in the nicotine salt liquid formulation; and
(c) the nicotine salt liquid formulation generates an inhalable aerosol upon heating in the electronic cigarette.

### Claim 2 (depends on 1)

The electronic cigarette cartridge of claim 1, wherein the liquid carrier comprises glycerol, propylene glycol, trimethylene glycol, water, ethanol or combinations thereof.

### Claim 3 (depends on 2)

The electronic cigarette cartridge of claim 2, wherein the liquid carrier comprises propylene glycol and glycerol.

### Claim 4 (depends on 1)

The electronic cigarette cartridge of claim 1, wherein the salt is present in an amount that forms a nicotine concentration of 1% (w/w) to 18% (w/w) in the nicotine salt liquid formulation.

### Claim 5 (depends on 4)

The electronic cigarette cartridge of claim 4, wherein the salt is present in an amount that forms a nicotine concentration of 3% (w/w) to 15% (w/w) in the nicotine salt liquid formulation.

### Claim 6 (depends on 4)

The electronic cigarette cartridge of claim 4, wherein the salt is present in an amount that forms a nicotine concentration of 4% (w/w) to 12% (w/w) in the nicotine salt liquid formulation.

### Claim 7 (depends on 1)

The electronic cigarette cartridge of claim 1, wherein the organic acid is formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, caprylic acid, capric acid, citric acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, phenylacetic acid, benzoic acid, pyruvic acid, levulinic acid, tartaric acid, lactic acid, malonic acid, succinic acid, fumaric acid, finnaric acid, gluconic acid, saccharic acid, salicylic acid, sorbic acid, malonic acid, malic acid, or a combination of two or more thereof.

### Claim 8 (depends on 1)

The electronic cigarette cartridge of claim 1, wherein the nicotine salt liquid formulation further comprises a flavorant.

### Claim 9 (depends on 1)

The electronic cigarette cartridge of claim 1, wherein the nicotine salt liquid formulation further comprises one or more additional organic acids.

### Claim 10 (depends on 1)

An electronic cigarette comprising the electronic cigarette cartridge of claim 1 and a heater.

### Claim 11

An electronic cigarette comprising a nicotine salt liquid formulation and a heater, wherein the nicotine salt liquid formulation comprises about 0.5% (w/w) to 20% (w/w) of a nicotine salt, wherein the nicotine salt comprises nicotine and an organic acid.

### Claim 12 (depends on 11)

The electronic cigarette of claim 11, wherein the organic acid is formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, caprylic acid, capric acid, citric acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, phenylacetic acid, benzoic acid, pyruvic acid, levulinic acid, tartaric acid, lactic acid, malonic acid, succinic acid, fumaric acid, finnaric acid, gluconic acid, saccharic acid, salicylic acid, sorbic acid, malonic acid, malic acid, or a combination of two or more thereof.

### Claim 13

A method of providing nicotine to a user, the method comprising heating a nicotine salt liquid formulation in an electronic cigarette to produce an inhalable aerosol, and inhalation of the aerosol by the user; wherein:
(i) the nicotine salt liquid formulation comprises a nicotine salt in a liquid carrier, wherein the nicotine salt comprises nicotine and an organic acid; and
(ii) the nicotine salt is present in an amount that forms a nicotine concentration of 0.5% (w/w) to 20% (w/w) in the nicotine salt liquid formulation.

### Claim 14 (depends on 13)

The method of claim 13, wherein the liquid carrier comprises glycerol, propylene glycol, trimethylene glycol, water, ethanol or combinations thereof.

### Claim 15 (depends on 14)

The method of claim 14, wherein the liquid carrier comprises propylene glycol and glycerol.

### Claim 16 (depends on 13)

The method of claim 13, wherein the salt is present in an amount that forms a nicotine concentration of 1% (w/w) to 18% (w/w) in the nicotine salt liquid formulation.

### Claim 17 (depends on 16)

The method of claim 16, wherein the salt is present in an amount that forms a nicotine concentration of 3% (w/w) to 15% (w/w) in the nicotine salt liquid formulation.

### Claim 18 (depends on 16)

The method of claim 16, wherein the salt is present in an amount that forms a nicotine concentration of 4% (w/w) to 12% (w/w) in the nicotine salt liquid formulation.

### Claim 19 (depends on 13)

The method of claim 13, wherein the nicotine salt liquid formulation further comprises a flavorant.

### Claim 20 (depends on 13)

The method of claim 13, wherein the nicotine salt liquid formulation further comprises one or more additional organic acids.
